BioSpace News Archive

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will report its financial results for the second quarter ended June 30, 2020, and provide an update on recent business highlights, on July 30, 2020. The Company will host a conference call and webcast on the same day at 8:30 a.m. ET to discuss the

CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of acute and severe inflammatory diseases, today announced data from a randomized, controlled, open-label clinical study showing substantially improved outcomes with Auxora™ (formerly called CM4620-IE) as a treatment for severe COVID-19 pneumonia.

Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, and has a Phase 2 ready norovirus vaccine program, today announced that a new study was published in the Journal of Infectious Diseases today, which concluded that norovirus gastroenteritis costs the United States an estimated median of $10.6 billion each year. In part

Emmaus Life Sciences, Inc. (OTCQB: EMMA) , a leader in sickle cell disease treatment, is pleased to announce that it has engaged Partner International to lead the out-licensing activity for Emmaus’ prescription grade L-glutamine (PGLG) oral powder for use in the treatment of diverticulosis. This is the same active pharmaceutical ingredient found in Endari®, which is approved by the FDA and the Israeli Ministry of Health to reduce acute co

A newly discovered type of cell present in the blood may predict episodes of joint inflammation known as flares in people with rheumatoid arthritis a week or two before the episodes occur, according to a study by researchers at Rockefeller University/Hospital for Special Surgery (HSS), Brigham and Women’s Hospital and Princeton University

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2020 financial performance in a press release before the market opens on Tuesday, August 4, 2020 and to host an earnings call to discuss the results following th

El Milagro Clinic announced it has launched rapid COVID-19 testing, together with CVS Health, at its clinic in the Rio Grande Valley.

The Ibn Sina Foundation announced it is launching a second COVID-19 testing site, together with CVS Health, at its Ibn Sina North Shepherd Community Clinic location.

Cambridge Semantics Aiding Merck KGaA, Darmstadt, Germany in Modernizing its Data Integration Capabilities and in Forging Multiple Data-driven Initiatives BOSTON--( BUSINESS WIRE )-- Cambridge Semantics, the leading provider of modern, graph-driven data integration for the enterprise data fabric, today announced that Merck KGaA, Darmstadt, Germany and its US-based biopharmaceutical business EMD Serono, have selected Cambridge Semantics as its dat

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced a partnership for the engineering and optimization of novel antibodies for the treatment of serious diseases in dogs and cats. “Many dis